Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 109,766 shares at $100.57 ($11.2M) on 2020-09-18, disclosed to the SEC on 2020-09-22.
Open-market sale of $11.2M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.57 | 12,801 | $1.3M | 11.5% |
| 2 | $100.57 | 12,801 | $1.3M | 11.5% |
| 3 | $101.55 | 13,834 | $1.4M | 12.6% |
| 4 | $101.55 | 13,834 | $1.4M | 12.6% |
| 5 | $102.53 | 17,709 | $1.8M | 16.2% |
| 6 | $102.53 | 17,709 |
| $1.8M |
| 16.2% |
| 7 | $103.00 | 21,078 | $2.2M | 19.4% |
| Total | $101.92 avg | 109,766 | $11.2M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |